Literature DB >> 9302213

Hemagglutination is a novel biological function of lipopolysaccharide (LPS), as seen with the Vibrio cholerae O139 LPS.

M Alam1, S Miyoshi, K Tomochika, S Shinoda.   

Abstract

It has been generally thought that the polysaccharide moiety of lipopolysaccharide (LPS) maintains only serological specificity, while the lipid A portion determines various biological functions. However, we found that hemagglutination was a common function of the polysaccharide moiety of LPSs from important human enteropathogenic bacteria. Of the LPSs examined, Vibrio cholerae O139 LPS showed the highest hemagglutinating activity. Glycoproteins, such as mucin and fetuin, showed efficient inhibition of the hemagglutinating ability. Since cell-mediated hemagglutination is known to be correlated with bacterial adherence, hemagglutination induced by the polysaccharide moiety is interpreted to indicate that cell-surface LPS is a potential adhesin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302213      PMCID: PMC170606          DOI: 10.1128/cdli.4.5.604-606.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity.

Authors:  G W Jones; G D Abrams; R Freter
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  Purification and characterization of novel hemagglutinins from Vibrio mimicus: a 39-kilodalton major outer membrane protein and lipopolysaccharide.

Authors:  M Alam; S I Miyoshi; K I Tomochika; S Shinoda
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Molecular organization of the rigid layer and the cell wall of Escherichia coli.

Authors:  V Braun
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.

Authors:  M M Levine; D R Nalin; J P Craig; D Hoover; E J Bergquist; D Waterman; H P Holley; R B Hornick; N P Pierce; J P Libonati
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

Review 5.  Vibrio cholerae O139 Bengal.

Authors:  M J Albert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

6.  Biological activities of lipopolysaccharide isolated from Vibrio cholerae O139, a new epidemic strain for recent cholera in Indian subcontinent.

Authors:  T Shimizu; Y Yanagihara; Y Isshiki; Y Kawamata; S Kondo; K Hisatsune
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

7.  The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae.

Authors:  V Sperandio; J A Girón; W D Silveira; J B Kaper
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Expression of virulence-related properties by, and intestinal adhesiveness of, Vibrio mimicus strains isolated from aquatic environments.

Authors:  M Alam; S Miyoshi; S Yamamoto; K Tomochika; S Shinoda
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

9.  Purification and characterization of a cell-associated hemagglutinin of Vibrio parahaemolyticus.

Authors:  K Nagayama; T Oguchi; M Arita; T Honda
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.

Authors:  W H Mosley; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

View more
  2 in total

1.  Induction of phenoloxidase and other immunological activities in the humoral fluids of amphioxus Branchiostoma belcheri challenged with Lipopolysaccharide (LPS).

Authors:  Qiuxiang Pang; Xuemei Liu; Bosheng Zhao; Huanhuan Sun
Journal:  Fish Physiol Biochem       Date:  2012-06-26       Impact factor: 2.794

2.  Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii.

Authors:  Hadi Abd; Amir Saeed; Andrej Weintraub; Gunnar Sandström
Journal:  J Med Microbiol       Date:  2009-01       Impact factor: 2.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.